FITC Anti-Human CD5 Antibody[UCHT2]

The FITC Anti-Human CD5 Antibody [UCHT2] is a highly specific and reliable tool designed for the detection and analysis of CD5 expression in human samples. This antibody is conjugated with fluorescein isothiocyanate (FITC), a fluorochrome known for its exceptional brightness and stability, ensuring accurate and consistent results.

CD5, also known as T1 antigen, is a cell surface glycoprotein primarily expressed on T cells and a subset of B cells. It plays a crucial role in T cell development, activation, and differentiation. Aberrant CD5 expression has been associated with various hematological malignancies, making it a valuable marker for diagnostic and prognostic purposes.

The FITC Anti-Human CD5 Antibody [UCHT2] has been extensively validated for flow cytometry applications, enabling the identification and enumeration of CD5-positive cells with high sensitivity and specificity. Its exceptional binding affinity and low background staining ensure reliable and accurate results, even in samples with low CD5 expression levels.

This antibody is supplied in a liquid format, ready for immediate use. It is provided in a convenient size of 100 tests, allowing for multiple experiments and reducing the need for frequent reordering. The FITC conjugation provides excellent signal detection and compatibility with other fluorochromes, facilitating multiparametric analysis.

The FITC Anti-Human CD5 Antibody [UCHT2] is manufactured under strict quality control standards to ensure batch-to-batch consistency and reproducibility. It is produced using advanced recombinant DNA technology and purified through a combination of chromatographic techniques, resulting in a highly pure and specific antibody.

In summary, the FITC Anti-Human CD5 Antibody [UCHT2] is a reliable and high-quality tool for the detection and analysis of CD5 expression in human samples. Its exceptional sensitivity, specificity, and compatibility make it an essential component for researchers and clinicians working in the fields of immunology, oncology, and hematology.